Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/2E8 stock hub

FRA/2E8 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/2E8is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.3B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/2E8

In the news

Latest news · FRA/2E8

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E27.9

P25 n/aP50 n/aP75 n/a

Trailing P/E43.1

P25 n/aP50 n/aP75 n/a

ROE23.7

P25 n/aP50 n/aP75 n/a

ROIC12.2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/2E8 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

185

Groups with data

Currency

CNY

Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	DE
Employees	3,762
Employees Change	247%
Employees Change Percent	7.03
Enterprise value	EUR 4.7B
Exchange	Frankfurt Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 4.3B
Price	EUR 7.9
Price currency	EUR
Rev Per Employee	215,786.14x
Sic	2836
Symbol	fra/2E8
Website	https://www.henlius.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.32%
EV Earnings	46.38x
EV/EBIT	47.33x
EV/EBITDA	31.24x
EV/FCF	38.58x
EV/Sales	5.8x
FCF yield	2.79%
Forward P/E	27.89x
P/B ratio	9x
P/E ratio	43.08x
P/S ratio	5.34x
PE Ratio3 Y	26.95x
PE Ratio5 Y	29.77x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	12.26%
EBITDA Margin	17.45%
FCF margin	14.91%
Gross margin	74.77%
Gross Profit	EUR 607M
Gross Profit Growth	13.47%
Gross Profit Growth Q	26.96%
Gross Profit Growth3 Y	6.46%
Gross Profit Growth5 Y	9.51%
Net Income	EUR 100.7M
Net Income Growth	0.8%
Net Income Growth Q	0.63%
Net Income Growth3 Y	6.11%
Pretax Margin	12.18%
Profit Margin	12.41%
Profit Per Employee	EUR 26,770
ROA	4.45
Roa5y	0.62
ROCE	11.01
ROE	23.72
Roe5y	2.52
ROIC	12.17
Roic5y	2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth	0.03
EPS Growth Q	-1.15
EPS Growth3 Y	5.94
FCF Growth	-7.76%
FCF Growth Q	-57.36%
FCF Growth3 Y	16.47%
FCF Growth5 Y	2.93%
OCF Growth	5.13%
OCF Growth Q	-46.02%
OCF Growth3 Y	10.54%
OCF Growth5 Y	-1.63%
Revenue Growth	16.46x
Revenue Growth Q	29.17x
Revenue Growth3 Y	5.73x
Revenue Growth5 Y	8.54x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.58
Assets	EUR 1.5B
Cash	EUR 102.7M
Current Assets	EUR 434.7M
Current Liabilities	EUR 616.1M
Debt	EUR 438M
Debt EBITDA	EUR 2.91
Debt Equity	EUR 0.91
Debt FCF	EUR 3.62
Equity	EUR 482.3M
Interest Coverage	7.97
Liabilities	EUR 1B
Long Term Assets	EUR 1.1B
Long Term Liabilities	EUR 406.9M
Net Cash	EUR -335.3M
Net Cash By Market Cap	EUR -7.73
Net Debt EBITDA	EUR 2.37
Net Debt Equity	EUR 0.7
Net Debt FCF	EUR 2.77
Tangible Book Value	EUR 52.8M
Tangible Book Value Per Share	EUR 0.1

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.71
Inventory Turnover	2.51
Net Working Capital	EUR -6.3M
Quick ratio	0.54
Working Capital	EUR -177.2M
Working Capital Turnover	EUR -0.41

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	7.92
All Time High	9.05
All Time High Change	-12.71%
All Time High Date	2026-04-10
All Time Low	5.9
All Time Low Change	33.9%
All Time Low Date	2026-01-27
ATR	0.18
Ch YTD	28.46
High	8
High52	9.05
High52 Date	2026-04-17
High52ch	-12.71%
Low	7.9
Low52	5.9
Low52 Date	2026-01-27
Low52ch	33.9%
Ma50ch	-0.21%
RSI	41.7
RSI Monthly	0
RSI Weekly	54.58
Sharpe ratio	0.81x
Sortino ratio	1.49
Total Return	-0.45%
Tr YTD	28.46
Tr1m	-5.95%
Tr1w	-1.86%
Tr3m	16.18%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 99.5M
Operating Income Growth	-4.54
Operating Income Growth Q	-9.28
Operating Income Growth3 Y	-0.01
Operating margin	12.26

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	137,570,618%
Net Borrowing	1,138,005.7
Shares Insiders	0.59%
Shares Institutions	17.57%
Shares Qo Q	0.9%
Shares Yo Y	0.45%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 105.9M
Average Volume	0x
Bv Per Share	0.89
CAPEX	EUR -37.9M
Ch1m	-5.95
Ch1w	-1.86
Ch3m	16.18
Ch6m	18.23
Change	-2.47%
Change From Open	-1.25
Close	8.1
Days Gap	-1.23
Depreciation Amortization	43,146,961.9
Earnings Date	2026-05-26
EBIT	EUR 99.5M
EBITDA	EUR 141.6M
EPS	EUR 0.18
F Score	6
FCF	EUR 121.1M
FCF EV Yield	2.59x
Financing CF	-11,429,345
Fiscal Year End	December
Founded	2,010
Graham Number	1.90363
Graham Upside	-75.9
Income Tax	EUR -1.9M
Investing CF	-145,653,681
Is Primary Listing	0
Last Report Date	2025-12-31
Lynch Fair Value	EUR 1.12
Lynch Upside	-85.83
Ma20	8.55
Ma20ch	-7.55%
Net CF	950,649
Next Earnings Date	2026-05-26
Open	8
P FCF Ratio	35.83
P OCF Ratio	27.29
Position In Range	0
Ppne	321,869,208.5
Price Date	2026-05-08
Price EBITDA	EUR 30.63
Ptbv Ratio	82.13
Revenue	811,787,463x
SBC By Revenue	1.87x
Share Based Comp	15,162,535
Tax By Revenue	-0.23x
Tr6m	18.23%
Z Score	2.19

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/2E8 pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns FRA/2E8?

Insider, institutional, and short-interest positioning.

Institutional ownership

+17.6%

Share of float held by funds and institutions

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.4%

Negative means the company is buying back shares.

Technical

FRA/2E8 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.7

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.81

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/2E8

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/2E8 stock rating?

fra/2E8 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/2E8 analysis?

The full report lives at /stocks/fra/2E8/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/2E8?

The latest report frames fra/2E8 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/2E8 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.